ArticlePhotochemistry and photobiology
Photobiomodulation and platelet-rich fibrin in the gastrocnemius muscle submitted to calcaneal tendinopathy in rats.
Article in Photochemistry and photobiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Therapeutic Effect of Photobiomodulation and Single Intratendinous Injection at the Lesion Site of Platelet-Rich Fibrin in Inducted Tendinopathy.Journal of biophotonics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The study investigated the impact of different treatments on recovery from calcaneal tendinopathy in rats, focusing on the gastrocnemius muscle. Tendinopathy is caused by repetitive overload, leading to structural collagen damage and chronic muscle inflammation. Three therapeutic approaches were compared: photobiomodulation (PBM), advanced platelet-rich fibrin (A-PRF) injection, and a combination of the two. Seventy-five rats were separated into five groups: control (CON), injury (LES), PRF (A-PRF), photobiomodulation (PBM) and combined therapy (A-PRF + PBM). Tendinopathy was induced by compression of the calcaneal tendon. The treatment was applied at specific intervals, and the animals were assessed for muscle strength and subjected to histological and morphometric analysis of the muscle. LES showed the lowest muscle strength. The treated groups (PBM, A-PRF and A-PRF + PBM) had an increase in strength between days 7 and 21, but there were no signs of muscle damage or significant recovery in the muscle fibers. The combined therapy group showed greater production of type III collagen in the connective tissue, indicating a more significant repair effect. In contrast, the neuromuscular junctions in the groups treated with PRF were smaller, suggesting possible structural alterations. The combination of therapies showed superior results to treatment alone, promoting greater tissue repair in the gastrocnemius muscle, especially due to the increase in type III collagen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.